M aurizio Billi is the president and controlling shareholder of Eurofarma, a Brazilian pharmaceutical giant headquartered in São Paulo. Founded in 1972 by his father, Galliano Billi, the company has grown into one of the largest drug manufacturers in Brazil, known for producing generic versions of popular medications. Maurizio Billi joined the family business at a young age and was instrumental in its expansion, particularly its strategy of acquiring smaller laboratories across Latin America.
Under his leadership, Eurofarma has established a presence in over 20 countries, becoming a regional powerhouse in the pharmaceutical sector. Billi has focused on modernizing the company's production facilities and investing in research and development. He is also a passionate car racing enthusiast, owning a stock car racing team that competes in Brazil's premier motorsport series. His wealth is derived from his ownership of the privately held company, which continues to dominate the generic drug market in Brazil.
Advertisement
Maurizio Billi is a Brazilian businessman and billionaire, the President of Eurofarma, one of the largest pharmaceutical companies in Brazil. The company was founded by his father in 1972 and specializes in selling generic versions of drugs.
Eurofarma has expanded its operations to 22 countries across Central and South America and employs more than 12,600 people. The company reports over $1.8 billion in revenues.
Maurizio Billi's career has been dedicated to scaling Eurofarma into a multinational pharmaceutical enterprise. Under his leadership, Eurofarma aggressively expanded across Central and South America by acquiring medical suppliers, labs, and other pharmaceutical companies.
His structural contribution is tied to making essential medicines, including generic versions of drugs such as Viagra, accessible across a vast region. His wealth is secured by the immense regional scale and profitability of the pharmaceutical giant.
Advertisement
Father founds Eurofarma.
Eurofarma expands to 22 countries through strategic acquisitions.
Continues as President, guiding the pharmaceutical giant.
Maurizio Billi's wealth is concentrated in his controlling stake and continued leadership of the private pharmaceutical giant, Eurofarma.
Advertisement
Advertisement
No publicly available quotes.
Advertisement
+0.21% | +$6.20M
+0.13% | +$3.04M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content